Published in Obesity and Diabetes Week, January 25th, 2010
"A randomized, placebo-and monotherapy-controlled, double-blind, dose-finding trial was conducted from August 2005 to December 2006 in seven U. S. outpatient clinics. A total of 419 patients with uncomplicated obesity participated. Interventions included 24 wk of sustained-release bupropion (400 mg/d), immediate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week